Skip to main content
Mark Puder, MD, Pediatric (General) Surgery, Boston, MA, Boston Children's Hospital

MarkPuderMDPhD

Pediatric (General) Surgery Boston, MA

Associate Professor of Surgery, Boston Children's Hospital

Dr. Puder is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Puder's full profile

Already have an account?

Education & Training

  • Children's Hospital
    Children's HospitalFellowship, Pediatric Surgery, 1999 - 2001
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Surgery, 1988 - 1998
  • Harvard University
    Harvard UniversityPhD, 1993 - 1997
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Pediatrics, 1986 - 1988
  • Vanderbilt University School of Medicine
    Vanderbilt University School of MedicineClass of 1986

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1991 - 2025
  • American Board of Surgery Surgery
  • American Board of Surgery Pediatric Surgery

Awards, Honors, & Recognition

  • Boston Magazine Castle Connolly, 2013
  • Fellow (FAAP) American Academy of Pediatrics
  • Fellow (FACS) American College of Surgeons

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Alcresta Therapeutics Announces Preclinical Data Showing ALC-078 Cartridge Use in SBS Model Associated with Reduced Dependence on Parenteral Nutrition
    Alcresta Therapeutics Announces Preclinical Data Showing ALC-078 Cartridge Use in SBS Model Associated with Reduced Dependence on Parenteral NutritionMarch 16th, 2023
  • Worth the Fight: Finding Care for Short Bowel Syndrome
    Worth the Fight: Finding Care for Short Bowel SyndromeApril 23rd, 2019
  • An Evolving Story of Translational Research: A Decade After the Jacobson Promising Investigator Award
    An Evolving Story of Translational Research: A Decade After the Jacobson Promising Investigator AwardDecember 30th, 2017
  • Join now to see all

Grant Support

  • Cholestasis Reversal (Phase Ll): Efficacy Of LV Fish OilFood And Drug Administration2008–2010
  • Cholestasis Prevention: Efficacy Of IV Fish OilFood And Drug Administration2008–2009
  • Mechanisms Of Hepatic Steatosis PreventionNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2009

Professional Memberships

Hospital Affiliations